Bacteriorhodopsin Mutant Photovoltaics for Clean Energy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional photovoltaic technologies face challenges such as high production costs, environmental pollution during manufacturing, and toxicity issues due to the use of materials like cadmium, and inefficiencies in energy conversion.
Innovation Solution
The development of protein-based photovoltaics utilizing bacteriorhodopsin mutants that enhance packing, orientation, and thermodynamics, allowing for efficient solar energy conversion and hydrogen gas production without toxic materials, using variants that act as chloride ion pumps, covalently bind to surfaces, and form oriented multilayers for improved energy harvesting.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional silicon-based photovoltaic cells are used, then high efficiency energy conversion is achieved, but manufacturing costs are high and pollution is generated during manufacture
Solution Approach 1:
The patent changes the fundamental material parameter from silicon-based compounds to protein-based photovoltaic materials (specifically bacteriorhodopsin and its mutants). This parameter change enables the system to maintain photoactive functionality while eliminating the harmful manufacturing processes associated with silicon, such as high-temperature processing, toxic chemical treatments, and energy-intensive purification steps.
Solution Approach 2:
The patent employs protein-based photovoltaic materials that can be produced through biological processes (recombinant expression in bacteria or other hosts) rather than expensive semiconductor manufacturing. These protein materials can be synthesized more cheaply and with less environmental impact, though they may have shorter operational lifetimes than silicon cells.
2Ease of manufacture
If cadmium-containing photovoltaic cells are used, then manufacturing costs are reduced, but toxicity and environmental harm increase
Solution Approach 1:
The patent replaces expensive and toxic materials (cadmium, silicon) with biologically produced protein materials that are inherently non-toxic and can be manufactured more cheaply through fermentation and expression systems. The protein-based cells represent a disposable, environmentally benign alternative to persistent toxic materials.
Solution Approach 2:
The patent converts the typically harmful role of biological systems (which can be messy, hard to purify, and difficult to scale) into a benefit by using living cells as factories to produce the photovoltaic materials. The biological production process inherently uses water-based solvents, ambient temperatures, and renewable resources, transforming what could be manufacturing disadvantages into environmental advantages.
3Ease of manufacture
If amorphous silicon is used instead of crystalline silicon, then manufacturing cost is reduced, but energy conversion efficiency decreases
Solution Approach 1:
The patent employs composite protein structures (bacteriorhodopsin mutants with specific amino acid modifications) that combine the benefits of both crystalline and amorphous materials. The mutant proteins self-assemble into ordered multilayer structures with high packing efficiency, achieving crystalline-like order through biological self-assembly rather than high-temperature processing, thus maintaining high efficiency at lower manufacturing costs.
4Productivity
If protein-based photovoltaics with mutant rhodopsin are used, then energy conversion efficiency is enhanced and hydrogen gas production is achieved, but device complexity increases
Solution Approach 1:
The patent divides the photovoltaic function into separate specialized protein components: some mutant rhodopsin variants are optimized for light absorption and energy conversion, while other variants are engineered specifically for hydrogen production through water splitting. This segmentation allows each component to be optimized for its specific function while maintaining overall system efficiency.
Solution Approach 2:
The patent creates universal protein-based photovoltaic platforms that can perform multiple functions. The same basic bacteriorhodopsin scaffold can be mutated to achieve different functions (energy conversion, hydrogen production, chloride pumping), allowing a single platform technology to address multiple energy needs without requiring entirely different systems for each application.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in a two-fold enhancement of energy conversion efficiency and the ability to generate hydrogen gas, addressing the limitations of traditional photovoltaic systems while minimizing environmental impact.
Implementation Method 1
The protein in the protein-based photovoltaic cells is rhodopsin protein, preferably bacteriorhodopsin... convert solar energy effectively and efficiently to electricity
Implementation Method 2
One group of mutants described herein have the ability to pump chloride anions. These bacteriorhodopsin mutants (chloride ion pump mutants) function as a chloride ion pump for brine splitting.
Implementation Method 3
These bacteriorhodopsin mutants (covalent binding mutants) have one or more amino acids replaced by cysteine residues, which provides them with enhanced abilities over wild type to covalently bind to metal surfaces and metal-coated particles such as gold surfaces and gold-coated particles.
Data Source
AI summary
Protein-based photovoltaic cells and the manufacture and use of protein-based photovoltaic cells are described. In one embodiment, bacteriorhodopsin from Halobacterium salinarum, which undergoes structural transitions when irradiated with a given wavelength of light, is used as the protein in the protein-based photovoltaic cells. In another embodiment, mutant bacteriorhodopsin from H. salinarum is used. Exposure of the protein to sunlight causes proton transfer across a membrane resulting in the generation of an electrical charge. The protein can be oriented and/or layered on a substrate and modified by mutation to enhance transmembrane proton transfer, covalent binding to a substrate and layering. The protein-based photovoltaic cells sequentially or simultaneously generate hydrogen gas from water or salt, which also can be harnessed to produce electricity.